Lv4
550 积分 2025-07-27 加入
High Metabolic Tumor Volume Is Associated with Higher Toxicity and Decreased Efficacy of BCMA CAR-T Cell Therapy in Multiple Myeloma
7天前
已关闭
B- Cell Maturation Antigen (BCMA) Re-Emergence and Relapse Patterns Post-BCMA-Chimeric Antigen Receptor T Cell (CAR-T ) Therapy for Multiple Myeloma
7天前
已关闭
Dose- and Schedule-Dependent Immunomodulatory Effects of the Novel Celmod Agent CC-92480 in Patients with Relapsed/Refractory Multiple Myeloma
7天前
已完结
Safety and Efficacy of Fully Human BCMA CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase BCMA Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma
7天前
已关闭
Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma
7天前
已关闭
BCMA biology and therapeutic targeting in multiple myeloma: From ligand signaling to antigen escape
7天前
已完结
Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine
8天前
已完结
Immune-mediated side effects of cancer immunotherapies
2个月前
已完结
The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy
2个月前
已完结
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models
2个月前
已完结
皖公网安备34019202002308
